About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $148.38 | Open | $157.98 |
| Volume | 4.76M | Market Cap | 57.295B |
| Yield | Last Dividend |
| Moderna Shares Extend Gains As Jim Crame... | 9:45 AM |
| Moderna shares jumped higher Friday after Jim Cramer said the drugmaker is nearing the development of a vaccine that could protect against certain for... | |
| Moderna COVID-19 vaccine trial in kids a... | 9:10 AM |
| Moderna has completed enrollment for a Phase 2/3 study of its COVID-19 vaccine in adolescents ages 12 to 17. | |
| Bulgaria???s Health Minister: We Cannot ... | 9:09 AM |
| ???We shouldn???t count chickens before they are hatched,??? Health Minister Kostadin Angelov told journalists in Varna, where he is on a visit today ... | |
| Canada approves AstraZeneca???s COVID-19... | 8:14 AM |
| The approval of AstraZeneca's vaccine follows that of Pfizer and Moderna, both of which also require two doses. | |
| Astra, Sputnik vaccines face hurdles if ... | 4:03 AM |
| Moderna as well as Pfizer and partner BioNTech said in separate statements this week they are studying additional booster shots that target new varian... | |
| What???s latest on Covid vaccines? Here?... | 3:10 AM |
| Covid Vaccine Update: Developing a vaccine against the Coronavirus seems to be not enough as researchers are continuously trying to improve the qualit... | |
| Scientists Discover 'All-Natural' COVID ... | 2:45 AM |
| Scientists Discover 'All-Natural' COVID Treatment That Can Prevent 'Cytokine Storm' In Severe Patients A team of scientists from Israel and Iceland ha... | |
| Canada should invest in facilities to ma... | 02/25/21 |
| Canada should prepare for the next pandemic by investing in the necessary infrastructure to be able to produce vaccines domestically, says Canadian st... | |
| Coronavirus live news: France may impose... | 02/25/21 |
| French PM says worrying Covid spread in 20 areas; global death toll passes 2.5m; Brazil death toll passes 250,000. Follow latest updates Biden hails 5... | |
| Bill Gates: Third Shot May Be Needed to ... | 02/25/21 |
| With more than 40 million Americans having received at least the first dose of the Pfizer or Moderna vaccine, a third dose may be needed to prevent th... | |
| Fauci urges Americans to get vaccinated,... | 02/25/21 |
| Summary List Placement Top US infectious disease expert Dr. Anthony Fauci urged Americans to get a coronavirus vaccine and not to cherry-pick the bran... | |
| U.S. administers 68.3 million doses of C... | 02/25/21 |
| The United States has administered 68,274,117 doses of Covid-19 vaccines in the country as of Thursday morning and distributed 91,673,010 doses. The t... | |
| The US may reach herd immunity before su... | 02/25/21 |
| Pfizer and Moderna this week pledged to ship 140 million vaccine doses to the US over the next five weeks. Coupled with the EUA recently issued to Joh... | |
| Moderna just made this big announcement ... | 02/25/21 |
| More than 66 million coronavirus vaccine doses have been administered in the US so far since vaccinations began in December. Moderna's CEO said the co... | |
| Dr. Fauci says you shouldn???t do these ... | 02/25/21 |
| While the coronavirus vaccines from Pfizer and Moderna are 95% effective at preventing infection, it's by no means an excuse for anyone to stop follow... | |
| Second doses of Moderna vaccine expected... | 02/25/21 |
| Residents at Caressant Care McLaughlin long-term care in Lindsay expected to receive a second dose of Moderna vaccine on March 2. | |
| AstraZeneca and Moderna???s contrasting ... | 02/25/21 |
| While Moderna is being hailed as a national saviour in the US, AZ???s only gain so far has been goodwill Compare and contrast. AstraZeneca is currentl... | |
| Vaccine 'ramp-up phase': 1.3M Moderna do... | 02/25/21 |
| After weeks of uncertainty, Moderna Inc. has confirmed to the Canadian government that it will deliver 1.3 million doses of its COVID-19 vaccine next ... | |
| Moderna???s vaccine deals top $23 billio... | 02/25/21 |
| Medical boss departing as CEO declares COVID-19 works ???just the beginning.??? | |
| Moderna forecasts $18bn in sales of Covi... | 02/25/21 |
| Better than expected revenues will push US firm founded in 2010 into profit for first time Coronavirus ??? latest updates See all our coronavirus cove... | |
| Moderna predicts $18.4bn in sales as dea... | 02/25/21 |
| US based Moderna is expecting $18.4bn in sales after vaccine deals are successful with countries The post Moderna expects Covid-19 vaccine sales to to... | |
| People receiving the J&J vaccine may not... | 02/25/21 |
| J &J's vaccine combines genetic material from the coronavirus with the genes of virus that caused colds to induce an immune response, which is differe... | |
| J&J's coronavirus shot could dramaticall... | 02/25/21 |
| Summary List Placement A shot for every American. Political leaders and vaccine manufacturers have endeavored to meet this goal since the start of the... | |
| Moderna (MRNA) to increase vaccine suppl... | 02/25/21 |
| Shares of Moderna Inc. (NASDAQ: MRNA) were up 6% in morning trade on Thursday after the company reported its fourth quarter and full year 2020 earning... | |
| Kamala Harris says she suffered side eff... | 02/25/21 |
| Vice President Kamala Harris revealed on Thursday that she suffered minor side effects from her second dose of the COVID-19 vaccine. | |
| Why Merck Is Buying Autoimmune Disease D... | 02/25/21 |
| Merck & Co., Inc. (NYSE: MRK ) is making another big-ticket buy, this time to expand its presence in the autoimmune disease market. What Happened: Lar... | |
| Hold rating | 12:00 AM |
| Morgan Stanley maintains Equal-Weight rating and lowers Price Target from $215.00 to $201.00 | |
| Hold rating | 02/18/21 |
| Morgan Stanley maintains Equal-Weight rating and raises Price Target from $150.00 to $215.00 | |
| Strong Buy rating | 02/17/21 |
| Piper Sandler maintains Overweight rating and raises Price Target from $170.00 to $208.00 | |
| Underperform rating | 02/01/21 |
| SVB Leerink maintains Underperform rating and raises Price Target from $69.00 to $80.00 | |
| Hold rating | 02/01/21 |
| Wells Fargo maintains Equal-Weight rating and raises Price Target from $129.00 to $145.00 | |
| Strong Buy rating | 02/01/21 |
| Oppenheimer maintains Outperform rating and raises Price Target from $178.00 to $206.00 | |
| Hold rating | 01/22/21 |
| B of A Securities maintains Neutral rating and raises Price Target from $130.00 to $140.00 | |
| Hold rating | 12/16/20 |
| Jefferies downgrades from Buy to Hold rating and raises Price Target from $90.00 to $150.00 | |
| Hold rating | 12/16/20 |
| Morgan Stanley downgrades from Overweight to Equal-Weight rating and raises Price Target from $100.00 to $150.00 | |
| Buy rating | 12/01/20 |
| Argus Research maintains Buy rating and raises Price Target from $88.00 to $200.00 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Stock_Options | alps | 92.00 % | Follow |
| ABCT - Any Body Can Trade-make 4x+ of ur paid/500$ | ABCT | 89.00 % | Subscribe |
| InvestDojo - (Just for fun) Twitter: @IDAlerts | InvestDojo | 89.00 % | Subscribe |
| Trading Systems | Trading Systems | 83.00 % | Subscribe |
| Tech Trades | Tech Trades | 81.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.